Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The WE Study - Walking Easier with cerebral palsy
2014-002539-32Phase 4Completed
- Sponsor
- St. Olavs University Hospital
- Start
- Dec 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of onabotulinumtoxinA in cerebral palsy (CP), sponsored by St. Olavs University Hospital. Primary endpoint: Primary: Energy cost during walking. Started Dec 2014; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on 2014-002539-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002539-32.